OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 60 filers reported holding OYSTER PT PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $99 | -100.0% | 8,861 | -78.3% | 0.00% | 0.0% |
| Q3 2022 | $230,000 | +1816.7% | 40,911 | +1351.8% | 0.00% | – |
| Q2 2022 | $12,000 | +9.1% | 2,818 | +206.3% | 0.00% | – |
| Q1 2022 | $11,000 | -67.6% | 920 | -51.4% | 0.00% | -100.0% |
| Q4 2021 | $34,000 | +78.9% | 1,893 | +21.5% | 0.00% | – |
| Q3 2021 | $19,000 | -17.4% | 1,558 | +18.8% | 0.00% | -100.0% |
| Q2 2021 | $23,000 | +27.8% | 1,311 | +36.7% | 0.00% | – |
| Q1 2021 | $18,000 | -72.3% | 959 | -72.4% | 0.00% | -100.0% |
| Q4 2020 | $65,000 | -49.2% | 3,480 | -42.5% | 0.00% | +100.0% |
| Q3 2020 | $128,000 | +255.6% | 6,050 | +380.9% | 0.00% | 0.0% |
| Q2 2020 | $36,000 | +227.3% | 1,258 | +191.9% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | – | 431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |